Site search2021
- 2021.11.12PRBrightPath to Present Updates on the Pre-clinical Data of BP1210 at SITC 2021（214KB）
- 2021.10.5PRBrightPath to Update the Pre-clinical Data of BP1210 at SITC 2021
- 2021.9.24PRBrightPath's abstract on a CD73 antagonist antibody wins Best Poster Award at ESMO 2021（277KB）
- 2021.9.16PRBrightPath Presents New Data on Personalized Neoantigen Vaccine Platform at ESMO 2021（233KB）
- 2021.9.16PRBrightPath Presents Preclinical Data on a CD73 antagonist antibody at ESMO 2021（212KB）
- 2021.9.10PRBrightPath's Update on the Pre-clinical Data of BP1200 and BP1209
- 2021.5.13IRFinancial Results for the Fiscal Year ended March 31, 2021 [Japanese GAAP]（445KB）
- 2021.11.12PRBrightPath to Present Updates on the Pre-clinical Data of BP1210 at SITC 2021（214KB）
- 2021.10.5PRBrightPath to Update the Pre-clinical Data of BP1210 at SITC 2021
- 2021.9.24PRBrightPath's abstract on a CD73 antagonist antibody wins Best Poster Award at ESMO 2021（277KB）
- 2021.9.16PRBrightPath Presents New Data on Personalized Neoantigen Vaccine Platform at ESMO 2021（233KB）
- 2021.9.16PRBrightPath Presents Preclinical Data on a CD73 antagonist antibody at ESMO 2021（212KB）
- 2021.9.10PRBrightPath's Update on the Pre-clinical Data of BP1200 and BP1209